QTTB
Q32 Bio Inc
NASDAQ: QTTB · HEALTHCARE · BIOTECHNOLOGY
$5.60
+1.82% today
Updated 2026-04-30
Market cap
$83.68M
P/E ratio
2.36
P/S ratio
1.56x
EPS (TTM)
$2.42
Dividend yield
—
52W range
$1 – $8
Volume
0.3M
Q32 Bio Inc (QTTB) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | $14.22M | $137.53M | $259.09M | $310.57M | $263.74M | $211.72M | $61.77M | $47.06M | $92.33M |
| Cash & equivalents | $11.39M | $51.57M | $38.22M | $53.77M | $217.43M | $108.38M | $43.89M | $25.62M | $77.97M |
| Current assets | $11.99M | $131.60M | $221.69M | $266.58M | $219.56M | $191.91M | $46.85M | $28.72M | $81.88M |
| Total liabilities | $6.72M | $39.22M | $62.74M | $52.06M | $67.74M | $42.07M | $192.49M | $229.98M | $86.66M |
| Current liabilities | $6.38M | $8.86M | $22.52M | $12.37M | $22.66M | $17.23M | $57.87M | $14.11M | $16.46M |
| Long-term debt | — | — | — | — | — | $4.97M | $5.07M | $43.18M | $9.56M |
| Shareholder equity | $7.50M | $98.31M | $196.35M | $258.51M | $196.00M | $169.65M | $-130.71M | $-182.92M | $5.67M |
| Retained earnings | $-10.19M | $-40.18M | $-95.76M | $-199.67M | $-328.37M | $-424.13M | $-133.34M | $-187.08M | $-234.81M |
| Accounts receivable | $113260.00 | — | $800000.00 | $400000.00 | $400000.00 | $909000.00 | $1.06M | $755000.00 | $555000.00 |
| Inventory | — | — | — | $1.00 | — | $769000.00 | $1.75M | — | — |
| Goodwill | — | — | — | — | — | — | — | — | — |